North China Pharmaceutical Company.Ltd (SHA:600812)

SHA:600812 Revenue

North China Pharmaceutical Company.Ltd had revenue of 2.15B CNY in the quarter ending March 31, 2026, a decrease of -16.36%. This brings the company's revenue in the last twelve months to 8.82B, down -10.78% year-over-year. In the year 2025, North China Pharmaceutical Company.Ltd had annual revenue of 9.24B, down -6.36%.

• Revenue (ttm): 8.82B
• Revenue Growth: -10.78%
• P/S Ratio: 0.87
• Revenue / Employee: 884.53K
• Employees: 9,972
• Market Cap: 7.69B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	9.24B	-627.92M	-6.36%
Dec 31, 2024	9.87B	-250.63M	-2.48%
Dec 31, 2023	10.12B	-379.75M	-3.62%
Dec 31, 2022	10.50B	115.37M	1.11%
Dec 31, 2021	10.38B	-1.11B	-9.64%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 9, 2026

Data Sources Report a data error